Osaic Holdings’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,307
| Closed | -$49K | – | 7703 |
|
|
2022
Q3 | $49K | Sell |
3,307
-11,918
| -78% | -$139K | ﹤0.01% | 4928 |
|
|
2022
Q2 | $113K | Buy |
15,225
+8,362
| +122% | +$58.9K | ﹤0.01% | 4327 |
|
|
2022
Q1 | $62K | Buy |
6,863
+1,739
| +34% | +$13.4K | ﹤0.01% | 4951 |
|
|
2021
Q4 | $36K | Sell |
5,124
-3,213
| -39% | -$33.6K | ﹤0.01% | 5401 |
|
|
2021
Q3 | $95K | Buy |
8,337
+1,723
| +26% | +$25.2K | ﹤0.01% | 4577 |
|
|
2021
Q2 | $106K | Sell |
6,614
-557
| -8% | -$9.55K | ﹤0.01% | 4436 |
|
|
2021
Q1 | $128K | Sell |
7,171
-981
| -12% | -$16.9K | ﹤0.01% | 4159 |
|
|
2020
Q4 | $109K | Sell |
8,152
-9,536
| -54% | -$115K | ﹤0.01% | 3985 |
|
|
2020
Q3 | $209K | Buy |
17,688
+13,357
| +308% | +$163K | ﹤0.01% | 3215 |
|
|
2020
Q2 | $64K | Buy |
4,331
+2,955
| +215% | +$43.7K | ﹤0.01% | 4024 |
|
|
2020
Q1 | $20K | Buy |
+1,376
| New | +$26.1K | ﹤0.01% | 4649 |
|
Osaic Holdings's AERI Position: Q4 2022 in Review
Osaic Holdings sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 3,307 shares — an estimated $49K sold.
Osaic Holdings first reported a position in AERI in Q1 2020 and held it in 11 quarters. The position peaked at $209K in Q3 2020. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Osaic Holdings reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Osaic Holdings sold 3,307 Aerie Pharmaceuticals shares in Q4 2022, an estimated $49K.
- Osaic Holdings first reported a position in Aerie Pharmaceuticals in Q1 2020 and held it in 11 quarters.
- Osaic Holdings's Aerie Pharmaceuticals position peaked at $209K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.